The ‘Deliberate Practice Mindset’

Performance improvement is an interest of mine. I have previously blogged and podcasted about the strategies I employed to lift my game (from rock-bottom) when working in an extreme environment – a South African township ED. I first became aware of ‘deliberate practice’ after reading an excellent St. Emlyn’s post last year. I had never encountered the concept before, but […]

Read More…

Live and let die

Everyone dies. It’s a sad fact of life and a tough part of any healthcare professional’s day. Some deaths are unexpected, and hit us hard. Thankfully, there are those that we know are coming, and this gives us the opportunity to try to give that person a peaceful and comfortable end of their life, and for […]

Read More…

Primary Survey: November 2016.

Richard Body, Associate Editor The Manchester derby for paediatric early warning scores There is clearly a need for a validated physiological early warning score for specific use in the paediatric emergency department (PED). In this issue, Cotterill et al compare two paediatric early warning scores developed in Manchester: the Royal Manchester Children’s Hospital Early Warning […]

Read More…

Primary Survey September 2016: EMJ

This month’s primary survey from the EMJ. Emergency Triage and Treatment Course in primary care health centres in Guatamala Emergency triage Assessment and treatment (ETAT) course was developed by WHO in 1999 as part of its Integrated Management of Childhood Illnesses program for improving outcomes for children. It has been devised as a hospital based […]

Read More…

What’s the future of medical journals?

I had the pleasure of joining a panel discussion at the recent SMACC conference on the future of medical journals. I was delighted to share the stage with some real big hitters such as Richard Smith (ex editor of the BMJ) and Jeff Drazen (current editor in chief of the NEJM), together with some amazing […]

Read More…

The Alteplase Controversy Goes Prime Time

Just a few months ago, alteplase for acute ischemic stroke was assaulted in the pages of the BMJ. Academic debate on this subject is hardly novel, as the controversy within the ivory tower has dragged on almost since thrombolytics for stroke received therapeutic approval. However, as the use of alteplase grows, the number of patients […]

Read More…